GI Innovation

About:

GI Innovation is a global leader of microbiome drug development.

Website: http://www.gi-innovation.com

Top Investors: IMM Investment, Aju IB Investment, NH Investment & Securities, iMarket Korea, DS Asset Management

Description:

GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.